South San Francisco, CA — September 11th, 2019 —We send heartfelt congratulations to the laureates, Drs. Michael Shepard, Axel Ullrich and Dennis Slamon, and everyone who has played a role in the discovery and development of Herceptin. We look forward to seeing how such scientific innovation and risk taking will continue to help people with serious diseases. Explore stories from those who have been part of the HER2 journey, including our researchers and a clinician from the clinical trials.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.